Overview

  • Product name
    Anti-Nucleoprotein Crimean-Congo hemorrhagic fever virus antibody
  • Description
    Rabbit Polyclonal to Nucleoprotein Crimean-Congo hemorrhagic fever virus
  • Host species
    Rabbit
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Other species
  • Immunogen

    Synthetic peptide corresponding to Nucleoprotein Crimean-Congo hemorrhagic fever virus . Peptide sequences specific to Crimean-Congo hemorrhagic fever virus (CCHFV) Nucleoprotein.
    Database link: P89522

  • Positive control
    • Crimean Congo hemorrhagic fever virus-infected Vero cell lysate. HEK293 cell lysate transfected with recombinant Crimean Congo hemorrhagic fever virus nucleoprotein (N).

Properties

Applications

Our Abpromise guarantee covers the use of ab190657 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.005 µg/ml. Predicted molecular weight: 54 kDa.

Images

  • All lanes : Anti-Nucleoprotein Crimean-Congo hemorrhagic fever virus antibody (ab190657) at 0.005 µg/ml

    Lane 1 : mock infected Vero cell lysate
    Lane 2 : Crimean Congo hemorrhagic fever virus-infected Vero cell lysate
    Lane 3 : mock transfected HEK293 cell lysate
    Lane 4 : HEK293 cell lysate transfected with recombinant Crimean Congo hemorrhagic fever virus nucleoprotein (N)

    Developed using the ECL technique.

    Predicted band size: 54 kDa



    Western blot - Anti-Nucleoprotein Crimean Congo hemorrhagic fever virus (ab190657)

References

ab190657 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab190657.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up